Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial

Autor:	Harter, Philipp, Mouret-Reynier, Marie Ange, Pignata, Sandro, Cropet, Claire, González-Martín, Antonio, Bogner, Gerhard, Fujiwara, Keiichi, Vergote, Ignace, Colombo, Nicoletta, Nøttrup, Trine Jakobi, Floquet, Anne, El-Balat, Ahmed, Scambia, Giovanni, Guerra Alia, Eva Maria, Fabbro, Michel, Schmalfeldt, Barbara, Hardy-Bessard, Anne-Claire, Runnebaum, Ingo, Pujade-Lauraine, Eric, Ray-Coquard, Isabelle
Zdroj:	In Gynecologic Oncology February 2022 164(2):254-264
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect